| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.10. | REVIVA PHARMACEUTICALS HOLDINGS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| REVIVA PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 14.10. | Birla Cellulose launches Liva Reviva M, pioneering circular fashion | 2 | fibre2fashion | ||
| 26.09. | Reviva Pharmaceuticals senkt Präsenzquorum für Hauptversammlungen | 17 | Investing.com Deutsch | ||
| 19.09. | REVIVA PHARMACEUTICALS HOLDINGS, INC. - 8-K, Current Report | 13 | SEC Filings | ||
| 19.09. | Reviva-Aktie stürzt nach Kapitalmaßnahme ab | 564 | FXStreet | Die Anteilsscheine von Reviva Pharmaceuticals brachen am Freitag im vorbörslichen Handel um rund 38 Prozent ein. Auslöser war die Ankündigung einer Kapitalerhöhung, mit der das Biopharma-Unternehmen... ► Artikel lesen | |
| 19.09. | Reviva Pharmaceuticals stock plunges after pricing $9 million offering | 1 | Investing.com | ||
| 19.09. | Reviva Pharmaceuticals announces pricing of $9M public offering | 1 | Seeking Alpha | ||
| 19.09. | Reviva Pharmaceuticals prices $9 million public offering | 1 | Investing.com | ||
| 19.09. | Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| 18.09. | Reviva Pharmaceuticals announces public offering of common stock | 1 | Investing.com | ||
| 18.09. | Reviva Pharmaceuticals kündigt öffentliche Aktienemission an | 1 | Investing.com Deutsch | ||
| 18.09. | Reviva Pharmaceuticals announces proposed public offering | 2 | Seeking Alpha | ||
| 18.09. | Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering | 1 | GlobeNewswire (USA) | ||
| 20.08. | Frequency Exchange Corp: Frequency signs int'l distribution deal with Reviva | 3 | Stockwatch | ||
| 14.08. | Reviva Pharmaceuticals GAAP EPS of -$0.12 in-line | 3 | Seeking Alpha | ||
| 14.08. | Reviva Pharmaceuticals: Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights | 132 | GlobeNewswire (Europe) | - Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial- - Successful... ► Artikel lesen | |
| 26.06. | REVIVA PHARMACEUTICALS HOLDINGS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 26.06. | Reviva Dives on Stock Offering | 2 | Baystreet.ca | ||
| 26.06. | Reviva Pharmaceuticals holdings announces pricing of $10M public offering | 2 | Seeking Alpha | ||
| 26.06. | Reviva preist öffentliches Angebot von 10 Millionen US-Dollar zu 0,50 US-Dollar pro Aktie | 2 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 27,585 | -0,68 % | Fast 150 % Kurschance! Plug Power, Bayer, Planethic Group Aktie | Bietet sich bei der Planethic Group (vormals Veganz Group) die Kaufchance des Herbstes? Analysten sehen jedenfalls über 100 % Kurspotenzial. Die jüngste Korrektur scheint übertrieben und lockt zum Einstieg.... ► Artikel lesen | |
| NOVO NORDISK | 45,045 | -1,39 % | Märkte am Morgen: Thyssenkrupp Marine Systems, Novo Nordisk/Eli Lilly, American Express, L'Oreal | Der DAX ist zum Ende der vergangenen Woche deutlich unter die Räder gekommen. Am Freitag gab er über 1,8 Prozent ab. Befürchtungen um eine mögliche Bankenkrise in den USA machen die Runde. Heute deutet... ► Artikel lesen | |
| ROCHE | 285,70 | -1,72 % | Aktien Europa: Überwiegend Gewinne - Gerichtsurteil belastet BNP Paribas | AMSTERDAM/LONDON/PARIS/ZÜRICH (dpa-AFX) - Europas wichtigste Aktienmärkte haben am Montag keine gemeinsame Richtung gefunden. Der EuroStoxx 50 knüpfte mit einem Plus von 0,73 Prozent auf 5.648,09 Punkte... ► Artikel lesen | |
| VIATRIS | 8,908 | -0,93 % | How Viatris is Fighting Infectious Disease | NORTHAMPTON, MA / ACCESS Newswire / October 21, 2025 / Viatris has a long history in the fight against infectious disease, which accounts for eight of the top 10 causes of death in low-income countries.1... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,565 | +0,69 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 | ||
| CASSAVA SCIENCES | 3,267 | +0,40 % | CASSAVA SCIENCES INC - 8-K, Current Report | ||
| NEWRON PHARMACEUTICALS | 15,500 | +0,13 % | NEWRON PHARMACEUTICALS SPA: Jetzt entscheidet sich alles! | ||
| ORAMED PHARMACEUTICALS | 2,070 | +3,50 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
| COMPASS PATHWAYS | 5,450 | +0,93 % | AbbVie, Atai Life Sciences und Neural Therapeutics: Deals im Milliarden-Markt für Psychedelika | ||
| ACHIEVE LIFE SCIENCES | 4,200 | -2,21 % | Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer | SEATTLE and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development... ► Artikel lesen | |
| AURINIA PHARMACEUTICALS | 10,060 | -1,52 % | Aurinia to present new voclosporin data at rheumatology conferences | ||
| KAZIA THERAPEUTICS | 6,710 | 0,00 % | Kazia Therapeutics Limited: Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program | SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration... ► Artikel lesen | |
| ALLERGY THERAPEUTICS | 0,100 | +17,65 % | Allergy Therapeutics says peanut allergy vaccine trial progressing | ||
| LYRA THERAPEUTICS | 6,340 | 0,00 % | Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study | Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the AAO-HNS 2025 Annual Meeting WATERTOWN, Mass., Oct. 06... ► Artikel lesen | |
| WELLGISTICS HEALTH | 1,140 | 0,00 % | Datavault AI Inc.: DataVault AI and Wellgistics Health Announce Plans for PharmacyChain to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and ... | BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health... ► Artikel lesen |